One thing about that forward looking statement about the amount of drugs on hand and being processed that they should be able to handle 20,000 patients: that says nothing about having enough people employed to distribute that amount. The company is suffering growing pains, they'll need time to smooth out distribution channels, etc. The revenues are good for starters in my opinion. Don't focus so much on the first two quarters. If by the end of the first quarter in 2007, they aren't treating real close to that 20,000 patients, then I'll have some concerns.
yashidashi